Evidence map›Paper›PMID 25458894›Full record

ArticleStem cell reports2014

Fast and efficient neural conversion of human hematopoietic cells.

Julio Castaño, Pablo Menendez, Cristina Bruzos-Cidon, Marco Straccia, Amaia Sousa, Lorea Zabaleta, Nerea Vazquez, Amaia Zubiarrain, Kai-Christian Sonntag, Luisa Ugedo and 5 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. p75Science advances · 2026
    Article
  3. NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Transdifferentiation of human adult peripheral blood T cells into neurons.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Julio CastañoJosep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Barcelona 08036, Spain.
Pablo MenendezJosep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Barcelona 08036, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.
Cristina Bruzos-CidonDepartment of Pharmacology, Faculty of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa 48940, Spain.
Marco StracciaDepartment of Cell Biology, Immunology and Neurosciences, Faculty of Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona 08036, Spain; Centro de Investigaciones Biomédicas en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona 08036, Spain.
Amaia SousaLaboratory of Stem Cells and Neural Repair, Inbiomed, San Sebastian 20009, Spain.
Lorea ZabaletaCell Reprogramming and Differentiation Platform, Inbiomed, San Sebastian 20009, Spain.
Nerea VazquezLaboratory of Stem Cells and Neural Repair, Inbiomed, San Sebastian 20009, Spain.
Amaia ZubiarrainLaboratory of Stem Cells and Neural Repair, Inbiomed, San Sebastian 20009, Spain; Cell Reprogramming and Differentiation Platform, Inbiomed, San Sebastian 20009, Spain.
Kai-Christian SonntagDepartment of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.
Luisa UgedoDepartment of Pharmacology, Faculty of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa 48940, Spain.
Xonia Carvajal-VergaraCell Reprogramming and Differentiation Platform, Inbiomed, San Sebastian 20009, Spain.
Josep Maria CanalsDepartment of Cell Biology, Immunology and Neurosciences, Faculty of Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona 08036, Spain; Centro de Investigaciones Biomédicas en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona 08036, Spain.
Maria TorrecillaDepartment of Pharmacology, Faculty of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa 48940, Spain.
Rosario Sanchez-PernauteLaboratory of Stem Cells and Neural Repair, Inbiomed, San Sebastian 20009, Spain. Electronic address: rpernaute@inbiomed.org.
Alessandra GiorgettiJosep Carreras Leukemia Research Institute, Cell Therapy Program of the University of Barcelona, Barcelona 08036, Spain. Electronic address: agiorgetti@carrerasresearch.org.
Universitat de Barcelona · ESUniversity of the Basque Country · ESMcLean Hospital · US

Funding

miRNAs as regulators of gene expression in Parkinson DiseaseR21NS067335 · NINDS · MCLEAN HOSPITAL · PI SONNTAG, KAI CHRISTIAN · 2009 to 2010
$435k
NINDS NIH HHS R21 NS067335
6 · The paper itself

Abstract

Neurons obtained directly from human somatic cells hold great promise for disease modeling and drug screening. Available protocols rely on overexpression of transcription factors using integrative vectors and are often slow, complex, and inefficient. We report a fast and efficient approach for generating induced neural cells (iNCs) directly from human hematopoietic cells using Sendai virus. Upon SOX2 and c-MYC expression, CD133-positive cord blood cells rapidly adopt a neuroepithelial morphology and exhibit high expansion capacity. Under defined neurogenic culture conditions, they express mature neuronal markers and fire spontaneous action potentials that can be modulated with neurotransmitters. SOX2 and c-MYC are also sufficient to convert peripheral blood mononuclear cells into iNCs. However, the conversion process is less efficient and resulting iNCs have limited expansion capacity and electrophysiological activity upon differentiation. Our study demonstrates rapid and efficient generation of iNCs from hematopoietic cells while underscoring the impact of target cells on conversion efficiency.

Indexed as

Cell TransdifferentiationAC133 AntigenAntigens, CDCell ProliferationCells, CulturedCellular SenescenceFetal BloodGene ExpressionGene Expression ProfilingGlycoproteinsHumansImmunophenotypingLeukocytes, MononuclearMembrane PotentialsNeuronsPeptidesAC133 AntigenAntigens, CDGlycoproteinsPeptidesPROM1 protein, human

Identifiers

PMID25458894
PMCPMC4264063
OpenAlexW2125027878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.